Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Clement, A. B.
  • Hawkins, E. G.
  • Lichtman, A. H.
  • Cravatt, Benjamin

publication date

  • May 2003

journal

  • Journal of Neuroscience  Journal

abstract

  • A number of recent in vitro studies have described a role for endogenous cannabinoids ("endocannabinoids") as transsynaptic modulators of neuronal activity in the hippocampus and other brain regions. However, the impact that endocannabinoid signals may have on activity-dependent neural events in vivo remains mostly unknown and technically challenging to address because of the short half-life of these chemical messengers in the brain. Mice lacking the enzyme fatty acid amide hydrolase [FAAH (-/-) mice] are severely impaired in their ability to degrade the endocannabinoid anandamide and therefore represent a unique animal model in which to examine the function of this signaling lipid in vivo. Here, we show that the administration of anandamide dramatically augments the severity of chemically induced seizures in FAAH (-/-) mice but not in wild-type mice. Anandamide-enhanced seizures in FAAH (-/-) mice resulted in significant neuronal damage in the CA1 and CA3 regions of the hippocampus for the bicuculline and kainate models, respectively. Notably, in the absence of anandamide treatment, FAAH (-/-) mice exhibited enhanced seizure responses to high doses of kainate that correlated with greatly elevated endogenous levels of anandamide in the hippocampus of these animals. Collectively, these studies suggest that both exogenously administered and endogenously produced anandamide display FAAH-regulated proconvulsant activity and do not support a general neuroprotective role for this endocannabinoid in response to excitotoxic stimuli in vivo. More generally, these findings demonstrate that the disinhibitory actions of endocannabinoids observed in hippocampal slices in vitro may also occur in vivo.

subject areas

  • Amidohydrolases
  • Animals
  • Arachidonic Acids
  • Bicuculline
  • Cannabinoid Receptor Modulators
  • Convulsants
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Endocannabinoids
  • GABA Antagonists
  • Genetic Predisposition to Disease
  • Hippocampus
  • Kainic Acid
  • Limbic System
  • Mice
  • Mice, Knockout
  • Neurons
  • Neurotoxins
  • Polyunsaturated Alkamides
  • Seizures
scroll to property group menus

Research

keywords

  • CB1 receptor
  • anandamide
  • bicuculline
  • endocannabinoid
  • epilepsy
  • excitotoxicity
  • fatty acid amide hydrolase
  • kainate
  • seizure
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0270-6474

PubMed ID

  • 12736361
scroll to property group menus

Additional Document Info

start page

  • 3916

end page

  • 3923

volume

  • 23

issue

  • 9

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support